Clinical Trial Update: Inofolic NRT and the Metabolic Syndrome [NA]

View source ↗

Summary

Completed clinical trial from the University of Messina evaluating Inofolic NRT for metabolic syndrome and postmenopausal syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Postmenopausal Syndrome

Drugs mentioned

• Inofolic NRT (myo-inositol and folic acid)

Snippet

Sponsor: University of Messina | Conditions: Metabolic Syndrome, Postmenopausal Disorder | NA | Status: COMPLETED